News Delix Therapeutics to start clinical trial on novel psychoplastogen drug DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions Rowan DunneMay 9, 2023
Cannabis Delix gets recognized as leading start-up by Nature Biotechnology Renowned academic journal praises company for development of psychoplastogens Rowan DunneSeptember 14, 2022